Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 1/2 1Phase 1 1

Status

Completed 2Terminated 1Active not recruiting 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Genitourinary 2CNS 2

Conditions

Prostatic Neoplasms 1Neuroblastoma 1Kidney Neoplasms 1Glioma 1

Interventions

pembrolizumab 107Specimen Handling 78Magnetic Resonance Spectroscopy 69Carboplatin 67Cisplatin 66Biopsy 57Nivolumab 56Radiotherapy 49Cyclophosphamide 49Paclitaxel 48durvalumab 37Gemcitabine 37Radiation 36Dexamethasone 32olaparib 31Etoposide 31Rituximab 30Docetaxel 30Doxorubicin 28atezolizumab 27Ipilimumab 27Lenalidomide 26Taxes 25Pemetrexed 24Bevacizumab 24Vincristine 23Platinum 23Cytarabine 23Radiotherapy, Intensity-Modulated 22Prednisone 22

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Has results × Granulocyte-Macrophage Colony-Stimulating Factor × 90 days × Clear all
NCT03600350 2026-06-01

pTVG-HP and Nivolumab in Patients With Non-Metastatic PSA-Recurrent Prostate Cancer

University of Wisconsin, Madison

Phase 2 Active not recruiting
19 enrolled 10 charts
Genitourinary

Prostatic Neoplasms

NCT00458536 2026-05-19

Vaccination of Patients With Renal Cell Cancer With Dendritic Cell Tumor Fusions and GM-CSF

Beth Israel Deaconess Medical Center

Phase 1/2 Completed
38 enrolled 4 charts
Genitourinary

Kidney Neoplasms

NCT03334305 2026-04-23

ACTION

University of Florida

Phase 1 Terminated
18 enrolled 11 charts
CNS

Glioma

NCT01857934 2026-04-16

Therapy for Children With Advanced Stage Neuroblastoma

St. Jude Children's Research Hospital

Phase 2 Completed
153 enrolled 12 charts
CNS

Neuroblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡